| Breakdown | TTM | Mar 2025 | Sep 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.50M | 38.90M | 56.20M | 73.10M | 82.50M | 85.80M |
| Gross Profit | 11.80M | 14.80M | 19.60M | 20.90M | 27.60M | 22.50M |
| EBITDA | 15.10M | 16.40M | 7.50M | 6.90M | 15.80M | -10.50M |
| Net Income | 6.30M | 6.20M | 3.30M | -100.00K | 12.10M | -21.50M |
Balance Sheet | ||||||
| Total Assets | 26.30M | 28.70M | 22.40M | 30.60M | 36.80M | 35.60M |
| Cash, Cash Equivalents and Short-Term Investments | 3.00M | 4.30M | 5.00M | 7.10M | 9.20M | 6.90M |
| Total Debt | 8.80M | 8.80M | 19.90M | 20.00M | 20.20M | 20.40M |
| Total Liabilities | 36.40M | 38.10M | 52.50M | 32.40M | 35.30M | 78.60M |
| Stockholders Equity | -10.10M | -9.40M | -30.10M | -1.80M | 1.50M | -43.00M |
Cash Flow | ||||||
| Free Cash Flow | -2.60M | -1.50M | 2.50M | -800.00K | 2.70M | -4.40M |
| Operating Cash Flow | -2.60M | -1.50M | 4.80M | 1.50M | 5.60M | -4.00M |
| Investing Cash Flow | 15.50M | 14.80M | -2.30M | -2.30M | -2.90M | -400.00K |
| Financing Cash Flow | -12.60M | -14.00M | -4.50M | -1.20M | -500.00K | 5.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | £522.26M | 11.70 | 7.92% | ― | 13.21% | -54.35% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | £26.25M | -1.20 | 63.25% | ― | -1.96% | 28.69% | |
60 Neutral | £14.80M | -2.99 | -5.59% | ― | -1.65% | -454.55% | |
56 Neutral | £665.47M | 8.84 | -113.93% | 1.40% | 3.94% | ― | |
48 Neutral | £551.93M | 11.73 | 12.75% | ― | -20.36% | 44.33% | |
41 Neutral | £6.28M | -2.53 | -64.62% | ― | -30.78% | 86.44% |